Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 65

Using Haloperidol to Manage Acute Back Pain in the Emergency Department

Official title: Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Run by Western Michigan University School of Medicine · NCT06395428 · Data updated 2026-11-12

This study is testing whether Haloperidol can help relieve acute back pain in adults who come to the emergency department, comparing it to a common pain medication.

More Chronic Pain trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment75 (estimated)
SponsorWestern Michigan University School of Medicine
Academic / other
Locations1 site (Kalamazoo, Michigan)
StatusRecruiting
StartedJuly 9, 2024
Main results expectedApril 15, 2025
Study endsApril 15, 2027
Registry record updatedJuly 10, 2024
Trial IDNCT06395428 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 presenting with acute, non-traumatic back pain and a pain score greater than 5 cm on the VAS.

Probably not a fit

Patients with traumatic back pain, neurological abnormalities, or certain medical conditions such as glaucoma or Lewy Body Dementia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of Haloperidol for pain control in patients aged 18-65 who present to the emergency department with acute, non-traumatic back pain. A total of 150 participants will be enrolled and randomly assigned to receive either Haloperidol or Ketorolac Tromethamine. Pain levels will be assessed at 30, 60, and 90 minutes after administration, with follow-up conducted via telephone 24 hours later. The study aims to provide insights into alternative pain management strategies in emergency settings.

Why it matters

Potential benefit: If successful, this study could offer a new approach to managing acute back pain in emergency department settings.

How similar studies have gone: While the use of Haloperidol for pain management is not widely tested, similar studies have explored its efficacy in various pain conditions, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 - 65 years old
* Presenting to the Bronson ED with a chief complaint of acute, non-traumatic back pain
* VAS score \>5 cm

Exclusion Criteria:

* Back pain due to traumatic injury
* Experiencing saddle anesthesia
* Has bowel or bladder dysfunction
* Has an abnormal neurological exam
* Requires imaging in ED
* Has a Glascow coma score \<15
* Has one or more abnormal vital signs:

HR\>120, SBP\>180 or \<90, temperature \>38°, O2 saturation\<92%

* Has an allergy to ketorolac or haloperidol
* Has a known diagnosis of Lewy Body Dementia
* Has a known diagnosis of glaucoma.
* Is known to be pregnant or breastfeeding
* Is a prisoner or ward of the state
* Is unable to consent for themselves/ non-english speaking
* In the opinion of the attending physician or investigator the patient should not participate in the research

Where it's running

  • Bronson Methodist Hospital
    Kalamazoo, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: Jessica McCoy, MD — Western Michigan University Homer Stryker M.D. School of Medicine
  • Study coordinator: Jessica McCoy, MD
  • Email: jessica.mccoy@wmed.edu
  • Phone: 269-337-6600

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.